Metabolism is an important process in human’s body to produce energy from food consumed. The digestive system breakdowns food components such as carbohydrate, fats and proteins into acids and sugar required to energize body. Amino acid holds significance in human nutrition for absorption and digestion of protein in gut. Majority of amino acids released in protein degradation process are quickly re-united to form fresh protein. However, consumer with metabolic disorder encounters complexities in protein degradation. Genetic disorder in amino acid processing leads to amino acid metabolism disorders. Proper intake of nutrition supplement and medicine helps to recover from amino acid metabolism disorders. According to Future Market Insights report, the global amino acid metabolism disorder market is expected to reach US$ 1,030 Mn by the end of 2027. The market is expected to register a stable CAGR during the forecast period 2017 – 2027. Following insights have been excerpted from an exclusive interview between a journalist and market analyst associated with Future Market Insights.
Considering your exhaustive research over the recent past, what factors have facilitated the market growth of amino acid metabolism disorder treatment, till date?
Amino acids are identified as the building blocks of proteins necessary in degradation and building of proteins. Hereditary complications in processing of food results to disorders in metabolism of amino acids. Such disorder is primarily diagnosed in new born babies. Thereby newborns get tested right after birth to identify amino acid metabolism disorder such as ASA (Argininosuccinic acidemia), TYR I (Tyrosinemia type I), MSUD (Maple syrup urine disease) and CIT (Citrullinemia) among others. Increasing incidences of diagnosis of amino acid metabolism disorder has led to occurrence of severe health problems and likely to increase in mortality rate due to such disorder. Thus, increasing significance of newborn screening is expected to encourage adoption of amino acid metabolism disorders treatment across the globe.
What preventive measures are taken by practitioners and dieticians to treat amino acid metabolism disorder? Which sector do you think is likely to gain opportunities in future?
Depending upon baby’s condition, several nutrient supplement and medicine are included in amino acid metabolism disorder treatment. Babies with disorders like PKU (Phenylketonuria), CIT or ASA are likely to be treated via dialysis and transplants operations for damaged organs. Based on these factors, medical and healthcare industry is expecedt to be driven at moderate pace during the forecast period.
According to you, what’s most promising scenario for the expansion of the global amino acid metabolism disorder treatment market?
Based in regional analysis, industrialized economies such as North America and Europe are highly likely to remain prevalent in amino acid metabolism disorder treatment during the forecast period. The key market players in North America are expected to account for US$ 359 Mn by the end of 2027. Several countries such as the US, Spain, Germany, France and Spain are likely to achieve profitable gains owing to rising number of clinical trials related to amino acid metabolism disorders.
After developed regions, what’s your take on market growth for the Asia-Pacific excluding Japan (APEJ)?
Growing healthcare sector in the APEJ coupled with government initiatives to encourage medical tourism is expecedt to offer potential opportunities for market players. In addition, growing awareness about newborn’s health along with provision of advance medical facilities at hospitals is highly likely to have positive impact on market growth of amino acid metabolism disorder treatment in this region.
In term of sales channel, where do you think key player find healthy prospects for market expansion?
Based in sales channel, key player find several medium to reach end users across the globe. This includes, retail pharmacies, online sales and hospital pharmacies. Among these, companies offering preferences for amino acid metabolism disorder treatment are likely to attain maximum value share through hospital pharmacies. Depending upon product type, sales of carglumic acid is estimated to reach a value of US$ 185 Mn followed by sapropterin dihydrocholoride by the end of the forecast period.
Who, do you think, are the key stakeholders in the global amino acid metabolism disorder treatment market?
Several companies operation in amino acid metabolism disorder treatment are focusing to establish long term agreements with hospital chains in order to gain continuous supply of medicine and supplements in the long run. Companies are also making efforts to promote their brand on global level to reach consumer base via internet. Several companies located at North America and Europe such as GlaxoSmithKline PLC, AMINO GmbH, Merck KGaA, Recordati S.p.A., Koninklijke DSM N.V., Sanofi are expected to account for valuable market share during the forecast period. Market players operating in APEJ such as Shine Star (Hubei) Biological Engineering Co. and Civentichem, LLC and Japanese like Kyowa Hakko Kirin Co., Ltd are anticipated to witness fast growth in amino acid metabolism disorder treatment market.
Request Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-6359